Yarrow Bioscience, Inc. (YARW)
NASDAQ: YARW · Real-Time Price · USD
30.21
+1.36 (4.71%)
At close: Sep 4, 2026, 4:00 PM EDT
28.80
-1.41 (-4.67%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Yarrow Bioscience Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025
Period Ending
Dec '25
Net Income
-283.98
Change in Accounts Payable
4.51
Change in Other Net Operating Assets
280.03
Operating Cash Flow
0.56
Operating Cash Flow Growth
-

Financing Activities

Fiscal Year
FY 2025
Period Ending
Dec '25
Issuance of Common Stock
0.02
Other Financing Activities
-0.6
Financing Cash Flow
399.42

Net Cash Flow

Fiscal Year
FY 2025
Period Ending
Dec '25
Net Cash Flow
399.98

Additional Metrics

Fiscal Year
FY 2025
Period Ending
Dec '25
Change in Working Capital
284.54
SEC Filings: 10-K · 10-Q